Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Adis, Springer Healthcare 2023-09-01
Saila:	Ophthalmology and Therapy
Gaiak:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Sarrera elektronikoa:	https://doi.org/10.1007/s40123-023-00807-9

Antzeko izenburuak

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
nork: Treefa Shwani, et al.
Argitaratua: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
nork: İmren Akkoyun
Argitaratua: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
nork: Reem H. ElSheikh, et al.
Argitaratua: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
nork: Richard D. Semba, et al.
Argitaratua: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
nork: João Estarreja, et al.
Argitaratua: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
nork: Julia Nguyen, et al.
Argitaratua: (2024-02-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
nork: Kiruthika M, et al.
Argitaratua: (2025-02-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
nork: Răzvan Vasile ROPCIUC
Argitaratua: (2024-05-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
nork: Sonali Nashine
Argitaratua: (2021-09-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
nork: Niloofar Piri, et al.
Argitaratua: (2023-05-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
nork: Anat Loewenstein, et al.
Argitaratua: (2024-12-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
nork: Grace A. Borchert, et al.
Argitaratua: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
nork: M. M. Bikbov, et al.
Argitaratua: (2022-03-01)

Genetic Insights into Age-Related Macular Degeneration
nork: Bhumika, et al.
Argitaratua: (2024-07-01)

Early and intermediate age-related macular degeneration: update and clinical review
nork: García-Layana A, et al.
Argitaratua: (2017-10-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
nork: Ines Lains, MD, PhD, et al.
Argitaratua: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
nork: Nicola Ferrante, et al.
Argitaratua: (2022-04-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
nork: Sabrina L. Mitchell, et al.
Argitaratua: (2021-11-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
nork: Yujong Yi, et al.
Argitaratua: (2024-03-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
nork: Avaylon J, et al.
Argitaratua: (2020-05-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
nork: Elżbieta Nowak, et al.
Argitaratua: (2018-07-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
nork: Audrey Yan, et al.
Argitaratua: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
nork: Mayank Choubey, et al.
Argitaratua: (2023-11-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
nork: Ashwin Gupta, et al.
Argitaratua: (2022-01-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
nork: Rita Flores, et al.
Argitaratua: (2021-12-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
nork: Sanjay Kumar Mishra, et al.
Argitaratua: (2022-07-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
nork: Ngoc Thien Le, et al.
Argitaratua: (2023-12-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
nork: Shashikant Sharma, et al.
Argitaratua: (2021-03-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
nork: Saurav Mallik, et al.
Argitaratua: (2022-06-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
nork: Uday Pratap Singh Parmar, et al.
Argitaratua: (2025-01-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
nork: Mateusz Winiarczyk, et al.
Argitaratua: (2024-05-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
nork: Xiang Li, et al.
Argitaratua: (2024-12-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
nork: Deepali R Damkondwar, et al.
Argitaratua: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
nork: Yingbin Fu, et al.
Argitaratua: (2024-02-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
nork: Ramandeep Singh, et al.
Argitaratua: (2022-01-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
nork: Zofia Ulańczyk, et al.
Argitaratua: (2020-10-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
nork: S. V. Yanchenko, et al.
Argitaratua: (2023-01-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
nork: Enoch T. Peng, et al.
Argitaratua: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
nork: Karanvir Gill, et al.
Argitaratua: (2024-07-01)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
nork: Pongsachareonnont P, et al.
Argitaratua: (2018-09-01)